Results
Dr Lal PathLabs Q1 FY27 Net Profit Up 27% YoY
Dr Lal PathLabs reported Q1 FY27 revenue of ₹798 crore, up 19.1% YoY, with PAT growth of 27.2% to ₹170 crore.
EBITDA margin expanded to 31.0% driven by CGHS price hikes, favorable test mix, and operat
